Skip to main content

Nitazoxanide Disease Interactions

There are 2 disease interactions with nitazoxanide.

Moderate

Nitazoxanide (applies to nitazoxanide) diabetes

Moderate Potential Hazard, High plausibility. Applicable conditions: Diabetes Mellitus

Alinia (brand of nitazoxanide) oral suspension contains 1.48 grams of sucrose per 5 mL. The sugar content should be considered when this product is used in patients with diabetes.

Switch to professional interaction data

Moderate

Nitazoxanide (applies to nitazoxanide) renal/liver disease

Moderate Potential Hazard, Low plausibility. Applicable conditions: Renal Dysfunction, Biliary Obstruction

The pharmacokinetics of nitazoxanide in patients with compromised renal and/or hepatic function have not been studied. Therapy with nitazoxanide should be administered cautiously in patients with hepatic and biliary disease and/or renal disease.

Switch to professional interaction data

Nitazoxanide drug interactions

There are 27 drug interactions with nitazoxanide.

Nitazoxanide alcohol/food interactions

There is 1 alcohol/food interaction with nitazoxanide.


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.